| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/23/2010 | US7666982 extracellular markers whereby Notch signal transduction can be detected; these peptides (N beta ) are released from cells in proportion to Notch signal depending on presenilin; by detecting these peptides, Notch signal transduction, cell differentiation, apoptosis, Alzheimer's disease can be detected |
| 02/23/2010 | US7666979 Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same |
| 02/23/2010 | US7666842 Elastin peptide analogs and uses thereof |
| 02/23/2010 | US7666841 for the treatment of diseases and pathological alterations associated with excessive or deregulated TGF- beta 1 expression |
| 02/23/2010 | US7666840 α-Conotoxin peptides |
| 02/23/2010 | US7666839 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 02/23/2010 | US7666832 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666831 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666624 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 02/23/2010 | US7666434 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 02/23/2010 | US7666430 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 02/23/2010 | US7666429 Nucleic acids encoding a house dust mite allergen Der P III, and uses therefor |
| 02/23/2010 | US7666428 Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity |
| 02/23/2010 | US7666408 Virus-like particle of an RNA bacteriophage carrier attached to an angiotensin peptide through a nonpeptide bond to form an ordered and repetitive angiotensin peptide-carrier conjugate; treating/preventing hypertension, stroke, infarction, congestive heart failure, kidney failure and retinal hemorrhage |
| 02/23/2010 | US7666397 hair-binding peptide and hair conditioning agent |
| 02/23/2010 | US7666391 Therapeutic treating breast cancer |
| 02/23/2010 | CA2416949C Non-human animal model unresponsive to mycoplasma derived lipoprotein/lipopeptide |
| 02/23/2010 | CA2198899C Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 02/18/2010 | WO2010018384A1 T-cell antigen peptide from allergen for stimulation of il-10 production |
| 02/18/2010 | WO2010018182A1 Peptidic and peptidomimetic compounds for regulating autophagy |
| 02/18/2010 | WO2010017653A1 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof |
| 02/18/2010 | WO2010017587A1 Novel protease inhibitors |
| 02/18/2010 | US20100041868 Conserved neisserial antigens |
| 02/18/2010 | US20100041773 Disruptors of early/recycling endosomes |
| 02/18/2010 | US20100041614 Metastasis-specific peptides and their diagnostic and therapeutic applications |
| 02/18/2010 | US20100041612 Fragments of the Glucagon-Like Peptide-1 and Uses Thereof |
| 02/18/2010 | US20100041609 Interleukin-1 receptor antagonists, compositions, and methods of treatment |
| 02/18/2010 | US20100041604 Novel antiviral peptides against influenza virus |
| 02/18/2010 | US20100041597 Peptides targeted to protein kinase c isoforms and uses thereof |
| 02/18/2010 | US20100041593 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy |
| 02/18/2010 | US20100041589 Methods for preparing purified lipopeptides |
| 02/18/2010 | US20100041568 Tripodal cyclohexane derivatives and their use as carbohydrate receptors |
| 02/18/2010 | US20100041144 Mammalian Cytokine; Related Reagents |
| 02/18/2010 | US20100041072 Process for identifying a ligand that binds to the nep binding site for the smr1 pentapeptide |
| 02/18/2010 | US20100041028 Zinc finger binding domains for GNN |
| 02/18/2010 | US20100040862 Three-Dimensional Structure of Functional Material |
| 02/18/2010 | US20100040641 Peptide vaccines for cancers expressing tumor-associated antigens |
| 02/18/2010 | US20100040640 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide |
| 02/18/2010 | US20100040634 Methods and compositions for modulating hgf/met |
| 02/18/2010 | US20100040623 Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins |
| 02/18/2010 | US20100040590 Tumor-associated peptides binding to human leukocyte antigen (HLA) class II molecules |
| 02/18/2010 | US20100040542 Chelator conjugates |
| 02/18/2010 | CA2734379A1 Ragweed peptides for vaccine |
| 02/18/2010 | CA2733726A1 Novel protease inhibitors |
| 02/17/2010 | EP2154248A1 Compounds and methods for diagnosis of tuberculosis |
| 02/17/2010 | EP2154145A2 Dimerized peptide |
| 02/17/2010 | EP2153841A1 Vaccine comprising Amb 1 a peptides for use in the treatment of ragweed allergy |
| 02/17/2010 | EP2152881A2 Rumc peptides with antimicrobial activity |
| 02/17/2010 | EP2152728A2 Mammalian expression vector with a highly efficient secretory signal sequence |
| 02/17/2010 | EP2152727A1 Peptide standards |
| 02/17/2010 | EP2152726A1 Analgesic compounds |
| 02/17/2010 | EP2152299A2 Pharmaceutical and/or cosmetic composition containing aconitase-activating active ingredients |
| 02/17/2010 | EP1263954B1 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/17/2010 | CN101648994A Azepine argireline or pharmaceutically acceptable salt thereof and preparation method and application thereof |
| 02/17/2010 | CN101648993A Small peptide A with antibacterial and antitumor functions and applications thereof |
| 02/17/2010 | CN101648992A Small peptide B with antibacterial and antitumor functions and applications thereof |
| 02/17/2010 | CN101648991A Small peptide C with antibacterial and antitumor functions and applications thereof |
| 02/17/2010 | CN101648990A Small peptide D with antibacterial and antitumor functions and applications thereof |
| 02/17/2010 | CN100589839C Polypeptide and medicament composition containing polypeptide |
| 02/16/2010 | US7662913 Inclusion body tags for use as molecular beacon in identification of heterologous polypeptides |
| 02/16/2010 | US7662786 Dolastatin 15 derivatives |
| 02/16/2010 | US7662783 Inhibiting angiogenesis, solid tumor growth and metastasis in the tissue of a mammal by administering to the mammal an active agent comprising an angiogenesis-inhibiting amount of a selective antagonist of denatured collagen type-IV |
| 02/16/2010 | US7662633 Method of screening for inhibitors of osteopontin |
| 02/16/2010 | US7662592 in vitro biosynthesis; Lactobacillus, Streptococcus, Enterococcus strains |
| 02/16/2010 | CA2614785C Regulation of antigen presentation |
| 02/11/2010 | WO2010017332A2 Radioprotectants targeting thrombospondin-1 and cd47 |
| 02/11/2010 | WO2009131395A3 Angiogenic peptide |
| 02/11/2010 | US20100036091 Antibody-based diagnostics and therapeutics |
| 02/11/2010 | US20100036089 Methods for the Synthesis of Dicarba Bridges in Organic Compounds |
| 02/11/2010 | US20100035823 Ligands of sh3 domains |
| 02/11/2010 | US20100035822 Proline-rich peptides, pharmaceutical composition, use of one or more peptides and method of treatment |
| 02/11/2010 | US20100035821 Amide Linkage Cyclic Natriuretic Peptide Constructs |
| 02/11/2010 | US20100035820 Amidated dopamine neuron stimulating peptides for cns dopaminergic upregulation |
| 02/11/2010 | US20100035813 Recombinant e-selectin made in insect cells |
| 02/11/2010 | US20100035256 Enduracidin biosynthetic gene cluster from streptomyces fungicidicus |
| 02/11/2010 | US20100034846 Novel method for treating h.pylori infections |
| 02/11/2010 | US20100034842 Compositions Employing Alternative Reading Frame Polypeptides for the Treatment of Cancer and Infectious Disease |
| 02/11/2010 | US20100034841 Antigenic polypeptide usable as therapeutic agent for malignant neoplasm |
| 02/11/2010 | US20100034771 Combination Of Cytokine And Cytokine Receptor For Altering Immune System Functioning |
| 02/11/2010 | US20100034758 Peptides Modified with Triterpenoids and Small Organic Molecules: Synthesis and use in Cosmeceuticals |
| 02/11/2010 | US20100034740 Radiofluorination methods |
| 02/11/2010 | CA2733461A1 Methods of predicting cancer lethality using replikin counts |
| 02/11/2010 | CA2733117A1 Template-fixed peptidomimetics |
| 02/11/2010 | CA2732102A1 Radioprotectants targeting thrombospondin-1 and cd47 |
| 02/10/2010 | EP2151450A1 Method for processing microbiologically produced cyclic oligopeptides |
| 02/10/2010 | EP2150269A1 New cyclic peptide compounds |
| 02/10/2010 | EP2150265A1 Inhibitors of acetyl-coa carboxylase for treatment of neuronal hypometabolism |
| 02/10/2010 | EP1700119B1 Beta-lactamase cd4+ t-cell epitopes |
| 02/10/2010 | CN101643499A Binding peptide of mycobacterium tuberculosis and application thereof |
| 02/10/2010 | CN101643498A Method for separating and purifying thymopentin with polyamide hydrogen bond adsorption chromatograph |
| 02/10/2010 | CN101643497A HLA-A2 restrictive epitope polypeptide of LMP2A protein source and purpose thereof |
| 02/10/2010 | CN101643496A Oligonucleotide with immune suppression function |
| 02/10/2010 | CN100588660C Antigenic determinant of SARS coronavirus nucleocapsid protein and application thereof |
| 02/09/2010 | US7659366 Peptide with putative role in cytoskeletal protection |
| 02/09/2010 | US7659364 Decyclization of an oxazolidinone compound; N-methylmethionine chemical intermediates |
| 02/09/2010 | US7659255 Methods of inhibiting glutamate receptors by administering the tripeptide KDI |
| 02/09/2010 | US7659252 Transdermal delivery peptides and method of use thereof |
| 02/09/2010 | US7659244 Rapamycin peptides conjugates: synthesis and uses thereof |
| 02/09/2010 | US7658917 A beta aggregation core domain and a modifying group coupled thereto such that the compound alters the aggregation or inhibits the neurotoxicity of natural beta amyloid peptides when contacted with the peptides. |
| 02/09/2010 | CA2592180C Nanographite structure/metal nanoparticle composite |